Author

Christina Mascaro

Institution: Oryzon Genomics (Spain)

Observed institution: Oryzon Genomics (Spain)

OpenAlex ID: A5083297619

Safety, Phamacokinetics (PK), Pharmacodynamics (PD) and Preliminary Activity in Acute Leukemia of Ory-1001, a First-in-Class Inhibitor of Lysine-Specific Histone Demethylase 1A (LSD1/KDM1A): Initial Results from a First-in-Human Phase 1 Study

2016 · Tim Somervaille, Olga Salamero, et al. · Blood · 46

Works count: 1

Citation count: 46

H-index: 1

I10-index: 1